George M Szczech

Summary

Publications

  1. ncbi Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
    G M Szczech
    Triangle Pharmaceuticals, Inc, Durham, North Carolina 27707, USA
    Antimicrob Agents Chemother 44:123-30. 2000
  2. ncbi Reproductive toxicology profile of emtricitabine in mice and rabbits
    George M Szczech
    Triangle Pharmaceuticals, Inc, 4611 University Drive, PO Box 50530, Durham, NC 27717, USA
    Reprod Toxicol 17:95-108. 2003

Detail Information

Publications2

  1. ncbi Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
    G M Szczech
    Triangle Pharmaceuticals, Inc, Durham, North Carolina 27707, USA
    Antimicrob Agents Chemother 44:123-30. 2000
    ..These results support the clinical development of EMV as a treatment for HIV-1 infection in adult and pediatric patient populations...
  2. ncbi Reproductive toxicology profile of emtricitabine in mice and rabbits
    George M Szczech
    Triangle Pharmaceuticals, Inc, 4611 University Drive, PO Box 50530, Durham, NC 27717, USA
    Reprod Toxicol 17:95-108. 2003
    ..The development and fertility of F(1) progeny were unaffected by emtricitabine in a mouse pre- and post-natal study. These data demonstrate a favorable pre-clinical reproductive safety profile for emtricitabine...